Home » Topics » Conferences

Conferences
RSS

Bayer gives details on discovery of IRAK-4 inhibitors BAY-845 and BAY-839

Sep. 16, 2021

Discovery of OXS-00005, a small-molecule candidate for regenerative medicine

Sep. 16, 2021

HTL-0041178 shows efficacy in models of psychosis and cognitive impairment

Sep. 16, 2021

New potent and selective USP7 inhibitor S-205474 presented

Sep. 16, 2021

D-dimer predicts reduced DLCO in COVID-19-associated pneumonia

Sep. 15, 2021

Latrophilin-3 induces urothelial tumorigenesis and is a therapeutic target

Sep. 15, 2021

AZD-0095, selective MCT4 inhibitor with excellent potency in cancer models

Sep. 15, 2021

EPRS inhibitor DWN-12088 shows antifibrotic effects in vitro and in vivo

Sep. 15, 2021

Preclinical data presented for HIF-1 inhibitor LW-1564

Sep. 15, 2021

Conference data for Sept. 13, 2021: ESMO

Sep. 14, 2021

Data to be presented at ESMO Congress 2021, including: Harbour Biomed, Samsung Bioepis.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...